Xingxiang Pu

1.8k citations
76 papers · 1.0k indexed · h-index 17
Topics
Lung Cancer Treatments and Mutations (29 papers)Cancer Immunotherapy and Biomarkers (16 papers)Lung Cancer Research Studies (16 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE

In The Last Decade

Xingxiang Pu

65 papers receiving 1.0k citations

Peers

Xingxiang Pu
Comparison fields: 5 of 83
  • Molecular Biology 570
  • Cancer Research 514
  • Oncology 365
  • Pulmonary and Respiratory Medicine 253
  • Immunology 85
Replace Kevin Zarrabi with:
Kevin Zarrabi United States
Dongjian Ji China
Floris H. Groenendijk Netherlands
Andreas Varkaris United States
Xubin Deng China
Hanli Fan United States
Yuki Takano Japan
Xianzi Wen China
Ulrike Setinek Austria
Kentaro Jingushi Japan
Xingxiang Pu relative to Kevin Zarrabi United States Kevin Zarrabi's profile →
Citations per field
00.5×1.5×2.0×
Kevin Zarrabi · 1×
Citations per year

Countries citing papers authored by Xingxiang Pu

Since Specialization
Citations

This map shows the geographic impact of Xingxiang Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingxiang Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingxiang Pu more than expected).

Fields of papers citing papers by Xingxiang Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingxiang Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingxiang Pu. The network helps show where Xingxiang Pu may publish in the future.

Co-authorship network of co-authors of Xingxiang Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingxiang Pu. A scholar is included among the top collaborators of Xingxiang Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingxiang Pu. Xingxiang Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 9
5 2
6 1
7 1
8 2
9 0
10 2
11 1
12 0
13 0
14 8
15 35
16 2
17 62
18 15
19 50
20 10

About Xingxiang Pu

Xingxiang Pu is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 76 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Lung Cancer Research Studies (16 papers). The work is most often cited by research in Cancer Research (514 citations), Oncology (365 citations) and Molecular Biology (570 citations). Xingxiang Pu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guoliang Huang, Hongqiang Guo, Lin Wu, Ying Tian, Haoran Li, Chengcheng Guo, Li Jiang, Ye Shen, Qianzhi Wang and Kang Li. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026